• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患有化脓性汗腺炎的患者血清浓度和 S100A7(银屑病素)的皮肤表达。

Serum Concentration and Skin Expression of S100A7 (Psoriasin) in Patients Suffering from Hidradenitis Suppurativa.

机构信息

Department of Dermatology, Venereology and Allergology, Wrocław Medical University, Wrocław, Poland,

Department of Dermatology, Venereology and Allergology, Wrocław Medical University, Wrocław, Poland.

出版信息

Dermatology. 2021;237(5):733-739. doi: 10.1159/000510689. Epub 2020 Nov 17.

DOI:10.1159/000510689
PMID:33202403
Abstract

BACKGROUND

Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease. An important role of innate immune dysregulation in the pathogenesis of HS has been highlighted. S100A7 (psoriasin) is an innate, antimicrobial protein that exerts proinflammatory and chemotactic action.

OBJECTIVES

The objective of the study was to investigate serum concentrations of S100A7 in individuals with HS as compared to healthy controls. Further, we evaluated the expression of S100A7 in lesional HS skin as compared to perilesional (clinically uninvolved) HS skin and normal skin.

METHODS

Serum concentrations of S100A7 were evaluated with a commercially available ELISA kit. The expression of S100A7 in the skin was assessed using qRT-PCR and immunofluorescence staining.

RESULTS

We found increased expression of S100A7 in lesional HS skin as compared to perilesional HS skin (p = 0.0017). The expression of S100A7 in lesional HS skin was positively associated with serum C-reactive protein concentration and the severity of disease according to Hurley staging. The serum concentration of S100A7 in individuals with HS was decreased as compared to healthy controls and patients with psoriasis.

CONCLUSIONS

Upregulated in lesional HS skin, S100A7 may enhance the inflammatory process and contribute to the HS pathogenesis.

摘要

背景

化脓性汗腺炎(HS)是一种慢性炎症性皮肤病。先天免疫失调在 HS 的发病机制中起着重要作用。S100A7(银屑病素)是一种先天的、抗菌蛋白,具有促炎和趋化作用。

目的

本研究旨在比较 HS 患者与健康对照组的血清 S100A7 浓度。此外,我们还评估了 S100A7 在病变 HS 皮肤与病变周围(临床未受累)HS 皮肤和正常皮肤中的表达。

方法

使用商业 ELISA 试剂盒评估血清 S100A7 浓度。使用 qRT-PCR 和免疫荧光染色评估 S100A7 在皮肤中的表达。

结果

与病变周围 HS 皮肤相比,我们发现病变 HS 皮肤中 S100A7 的表达增加(p = 0.0017)。病变 HS 皮肤中 S100A7 的表达与血清 C-反应蛋白浓度和 Hurley 分期评估的疾病严重程度呈正相关。与健康对照组和银屑病患者相比,HS 患者的血清 S100A7 浓度降低。

结论

S100A7 在病变 HS 皮肤中上调,可能增强炎症过程并有助于 HS 的发病机制。

相似文献

1
Serum Concentration and Skin Expression of S100A7 (Psoriasin) in Patients Suffering from Hidradenitis Suppurativa.患有化脓性汗腺炎的患者血清浓度和 S100A7(银屑病素)的皮肤表达。
Dermatology. 2021;237(5):733-739. doi: 10.1159/000510689. Epub 2020 Nov 17.
2
Reduced ten-eleven translocation and isocitrate dehydrogenase expression in inflammatory hidradenitis suppurativa lesions.化脓性汗腺炎病变中10-11易位蛋白和异柠檬酸脱氢酶表达降低。
Eur J Dermatol. 2018 Aug 1;28(4):449-456. doi: 10.1684/ejd.2018.3369.
3
Expression of miRNA-155, miRNA-223, miRNA-31, miRNA-21, miRNA-125b, and miRNA-146a in the Inflammatory Pathway of Hidradenitis Suppurativa.miRNA-155、miRNA-223、miRNA-31、miRNA-21、miRNA-125b 和 miRNA-146a 在化脓性汗腺炎炎症通路中的表达。
Inflammation. 2017 Apr;40(2):464-472. doi: 10.1007/s10753-016-0492-2.
4
Inflammation induced changes in the expression levels of components of the microRNA maturation machinery Drosha, Dicer, Drosha co-factor DGRC8 and Exportin-5 in inflammatory lesions of hidradenitis suppurativa patients.炎症诱导化脓性汗腺炎患者炎症病灶中微小RNA成熟机制的组成成分Drosha、Dicer、Drosha辅助因子DGRC8和Exportin-5的表达水平发生变化。
J Dermatol Sci. 2016 Jun;82(3):166-74. doi: 10.1016/j.jdermsci.2016.02.009. Epub 2016 Feb 18.
5
Immunohistological pointers to a possible role for excessive cathelicidin (LL-37) expression by apocrine sweat glands in the pathogenesis of hidradenitis suppurativa/acne inversa.免疫组织化学指标表明大汗腺过度表达抗菌肽(LL-37)可能在化脓性汗腺炎/反向痤疮的发病机制中起作用。
Br J Dermatol. 2012 May;166(5):1023-34. doi: 10.1111/j.1365-2133.2011.10765.x. Epub 2012 Apr 4.
6
Primary alterations during the development of hidradenitis suppurativa.化脓性汗腺炎发展过程中的主要改变。
J Eur Acad Dermatol Venereol. 2022 Mar;36(3):462-471. doi: 10.1111/jdv.17779. Epub 2021 Nov 26.
7
The inflammatory proteome of hidradenitis suppurativa skin is more expansive than that of psoriasis vulgaris.化脓性汗腺炎皮肤的炎症蛋白质组比寻常型银屑病更广泛。
J Am Acad Dermatol. 2022 Feb;86(2):322-330. doi: 10.1016/j.jaad.2021.07.035. Epub 2021 Jul 30.
8
S100A7/psoriasin expression in the human lung: unchanged in patients with COPD, but upregulated upon positive S. aureus detection.S100A7/psoriasin 在人肺中的表达:在 COPD 患者中不变,但在阳性金黄色葡萄球菌检测时上调。
BMC Pulm Med. 2011 Feb 15;11:10. doi: 10.1186/1471-2466-11-10.
9
Altered Global 5-Hydroxymethylation Status in Hidradenitis Suppurativa: Support for an Epigenetic Background.化脓性汗腺炎中全球 5-羟甲基化状态的改变:对表观遗传背景的支持。
Dermatology. 2017;233(2-3):129-135. doi: 10.1159/000478043. Epub 2017 Jul 28.
10
Interleukin-32 is highly expressed in lesions of hidradenitis suppurativa.白细胞介素 32 在化脓性汗腺炎病变中高度表达。
Br J Dermatol. 2017 Nov;177(5):1358-1366. doi: 10.1111/bjd.15458. Epub 2017 Sep 27.

引用本文的文献

1
The impact of innate immunity and epigenetics in the pathogenesis of hidradenitis suppurativa.先天性免疫和表观遗传学在化脓性汗腺炎发病机制中的作用
Front Immunol. 2025 May 19;16:1593253. doi: 10.3389/fimmu.2025.1593253. eCollection 2025.
2
Increased expression of psoriasin (S100A7) and interleukin 17 (IL-17) in lesional skin in lichen planopilaris.扁平苔藓样毛发角化病皮损中牛皮癣素(S100A7)和白细胞介素17(IL-17)表达增加。
Postepy Dermatol Alergol. 2024 Aug;41(4):364-371. doi: 10.5114/ada.2024.142179. Epub 2024 Aug 12.
3
IL-17: a novel player in the pathogenesis of vulvar lichen sclerosus.
白细胞介素-17:外阴硬化性苔藓发病机制中的一个新角色。
Postepy Dermatol Alergol. 2024 Apr;41(2):220-225. doi: 10.5114/ada.2024.139142. Epub 2024 Apr 24.
4
Molecular chaos under the skin: Epigenetic reprogramming in hidradenitis suppurativa.皮下的分子紊乱:化脓性汗腺炎中的表观遗传重编程。
Proc Natl Acad Sci U S A. 2024 Jan 2;121(1):e2319797121. doi: 10.1073/pnas.2319797121. Epub 2023 Dec 26.
5
Epigenetic switch reshapes epithelial progenitor cell signatures and drives inflammatory pathogenesis in hidradenitis suppurativa.表观遗传开关重塑了大汗腺炎中上皮祖细胞特征,并驱动其炎症发病机制。
Proc Natl Acad Sci U S A. 2023 Dec 5;120(49):e2315096120. doi: 10.1073/pnas.2315096120. Epub 2023 Nov 27.
6
Sex-disaggregated population analysis in patients with hidradenitis suppurativa.化脓性汗腺炎患者的性别分类人群分析。
Front Med (Lausanne). 2022 Nov 1;9:1028943. doi: 10.3389/fmed.2022.1028943. eCollection 2022.
7
Innate immunity and microbial dysbiosis in hidradenitis suppurativa - vicious cycle of chronic inflammation.先天性免疫和微生物失调与化脓性汗腺炎-慢性炎症的恶性循环。
Front Immunol. 2022 Jul 28;13:960488. doi: 10.3389/fimmu.2022.960488. eCollection 2022.
8
IL-17A is a pertinent therapeutic target for moderate-to-severe hidradenitis suppurativa: Combined results from a pre-clinical and phase II proof-of-concept study.IL-17A 是中重度化脓性汗腺炎的一个有针对性的治疗靶点:临床前和 II 期概念验证研究的综合结果。
Exp Dermatol. 2022 Oct;31(10):1522-1532. doi: 10.1111/exd.14619. Epub 2022 Aug 19.
9
Identification of Biomarkers and Critical Evaluation of Biomarker Validation in Hidradenitis Suppurativa: A Systematic Review.在化脓性汗腺炎中鉴定生物标志物及对生物标志物验证的关键性评估:系统综述。
JAMA Dermatol. 2022 Mar 1;158(3):300-313. doi: 10.1001/jamadermatol.2021.4926.